Tytuł pozycji:
Estetrol/drospirenone (Nextstellis) - a new combination oral contraceptive.
-
Tytuł:
-
Estetrol/drospirenone (Nextstellis) - a new combination oral contraceptive.
-
Źródło:
-
The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2021 Jun 28; Vol. 63 (1627), pp. 101-102.
-
Typ publikacji:
-
Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: New Rochelle, NY : The Medical Letter
-
MeSH Terms:
-
Androstenes/*administration & dosage
Contraceptives, Oral/*administration & dosage
Contraceptives, Oral, Combined/*administration & dosage
Contraceptives, Oral, Hormonal/*administration & dosage
Estetrol/*administration & dosage
Administration, Oral ; Androstenes/adverse effects ; Contraceptives, Oral/adverse effects ; Contraceptives, Oral, Combined/adverse effects ; Contraceptives, Oral, Hormonal/adverse effects ; Drug Administration Schedule ; Drug Interactions ; Estetrol/adverse effects ; Female ; Humans
-
Contributed Indexing:
-
Keywords: Medroxyprogesterone; Nexplanon; Nextstellis; Slynd; adverse effects; dosage; drospirenone; drug interactions; efficacy; estetrol; estrogens; etonogestrel; oral contraceptives; progestins; safety
-
Substance Nomenclature:
-
0 (Androstenes)
0 (Contraceptives, Oral)
0 (Contraceptives, Oral, Combined)
0 (Contraceptives, Oral, Hormonal)
ENB39R14VF (Estetrol)
N295J34A25 (drospirenone)
-
Entry Date(s):
-
Date Created: 20210628 Date Completed: 20210712 Latest Revision: 20210712
-
Update Code:
-
20240105
-
PMID:
-
34181632
-